159 related articles for article (PubMed ID: 35781357)
1. Serum free light chain analysis: persisting limitations with new kids on the block.
Van Hoovels L; Vercammen M; Nevejan L; Cornette M; Briers PJ; Deeren D; Van Droogenbroeck J; Fostier K; De Smet D
Clin Chem Lab Med; 2022 Aug; 60(9):1440-1448. PubMed ID: 35781357
[TBL] [Abstract][Full Text] [Related]
2. Method comparison of three serum free light chain assays on the Roche Cobas 6000 c501 chemistry analyzer.
Augustijn D; Jacobs JFM; Russcher H
Clin Chem Lab Med; 2022 Feb; 60(3):379-385. PubMed ID: 34969184
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a new free light chain ELISA assay: bringing coherence with electrophoretic methods.
Jacobs JFM; de Kat Angelino CM; Brouwers HMLM; Croockewit SA; Joosten I; van der Molen RG
Clin Chem Lab Med; 2018 Jan; 56(2):312-322. PubMed ID: 28771430
[TBL] [Abstract][Full Text] [Related]
4. Method Comparison and Workflow Differences Using the Same Free Light Chain Assay on 2 Analyzer Platforms.
Omosule CL; Hock KG; Dalton C; Scalpati A; Gronowski AM; Brants A; Farnsworth CW
J Appl Lab Med; 2023 Jul; 8(4):689-699. PubMed ID: 37186660
[TBL] [Abstract][Full Text] [Related]
5. Clinical specificity of two assays for immunoglobulin kappa and lambda free light chains.
Farnsworth CW; Roemmich B; Spears GM; Murray DL; Dispenzieri A; Willrich MAV
Clin Chem Lab Med; 2024 Apr; 62(5):929-938. PubMed ID: 38044587
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the new Sebia free light chain assay using the AP22 ELITE instrument.
Lutteri L; Aldenhoff MC; Cavalier E
Clin Chim Acta; 2018 Dec; 487():161-167. PubMed ID: 30243748
[TBL] [Abstract][Full Text] [Related]
7. Verification of Newly FDA-Approved Kappa and Lambda Free Light Chain Assays on a Previously Untested Platform.
Muluhngwi P; Sharp CN; Pozzi N; Elin RJ; Jortani SA
J Appl Lab Med; 2019 Nov; 4(3):323-330. PubMed ID: 31659070
[TBL] [Abstract][Full Text] [Related]
8. Inter-assay variability in automated serum free light chain assays and their use in the clinical laboratory.
Caponi L; Romiti N; Koni E; Fiore AD; Paolicchi A; Franzini M
Crit Rev Clin Lab Sci; 2020 Mar; 57(2):73-85. PubMed ID: 31612753
[TBL] [Abstract][Full Text] [Related]
9. Performance Evaluation of Serum Free Light Chain Analysis: Nephelometry vs Turbidimetry, Monoclonal vs Polyclonal Reagents.
Messiaen AS; De Sloovere MMW; Claus PE; Vercammen M; Van Hoovels L; Heylen O; Debrabandere J; Vanpoucke H; De Smet D
Am J Clin Pathol; 2017 Jun; 147(6):611-622. PubMed ID: 28575180
[TBL] [Abstract][Full Text] [Related]
10. The association of serum-free light-chain levels with markers of renal function.
Erdem BK; Davran F; Yilmaz VT; Çetinkaya R; Akbas H
Ren Fail; 2015 Jul; 37(6):1057-60. PubMed ID: 26056734
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Freelite serum free light chain (SFLC) assay with serum and urine electrophoresis/immunofixation and the N Latex FLC assay.
Sasson SC; McGill K; Wienholt L; Carr A; Brown DA; Kelleher AD; Breit SN; Sewell WA
Pathology; 2015 Oct; 47(6):564-9. PubMed ID: 26352111
[TBL] [Abstract][Full Text] [Related]
12. Data analytics improves the diagnostic accuracy of serum free light chain results for detecting monoclonal gammopathy.
Treger RS; Mathias PC; Cowan AJ; Green D; Hutchinson K; Bryan A; Chaudhary A; Fink SL; Wener MH; Morishima C
Am J Clin Pathol; 2024 Mar; 161(3):216-231. PubMed ID: 37936261
[TBL] [Abstract][Full Text] [Related]
13. Clinical implication by differential analytical performances of serum free light chain quantitation analysis using fully automated analyzers.
Yun SY; Rim JH; Park H; Kang H; Lee SG; Lim JB
Clin Chem Lab Med; 2023 Jun; 61(7):1288-1299. PubMed ID: 37015073
[TBL] [Abstract][Full Text] [Related]
14. Serum Free Light Chain Quantification Testing: Comparison of Two Methods for Disease Monitoring.
Singh G; Whitaker BM; Wu AHB; Xu H; Bollag RJ
J Appl Lab Med; 2022 Oct; 7(6):1290-1301. PubMed ID: 36006797
[TBL] [Abstract][Full Text] [Related]
15. Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool.
Campbell JP; Heaney JL; Shemar M; Baldwin D; Griffin AE; Oldridge E; Goodall M; Afzal Z; Plant T; Cobbold M; Jefferis R; Jacobs JF; Hand C; Drayson MT
Clin Chem Lab Med; 2017 Mar; 55(3):424-434. PubMed ID: 27505089
[TBL] [Abstract][Full Text] [Related]
16. Serum free light chain reference intervals in an Optilite and their influence on clinical guidelines.
Morales-García LJ; Pacheco-Delgado MS
Clin Biochem; 2021 Jun; 92():54-60. PubMed ID: 33662349
[TBL] [Abstract][Full Text] [Related]
17. Serum Free Light Chain Assay: Shift Toward a Higher κ/λ Ratio.
Rindlisbacher B; Schild C; Egger F; Bacher VU; Pabst T; Leichtle A; Andres M; Sédille-Mostafaie N
J Appl Lab Med; 2020 Jan; 5(1):114-125. PubMed ID: 32445339
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the N-latex serum free light chain assay on the Siemens BNII analyzer and agreement with The Binding Site FreeLite assay on the SPA
White-Al Habeeb NMA; Earle T; Spencer M; Blasutig IM
Clin Biochem; 2018 Jan; 51():90-96. PubMed ID: 28512013
[TBL] [Abstract][Full Text] [Related]
19. Freelite and Kloneus assays in free light chain measurements in patients with renal impairment.
Morales-García LJ; Lillo Rodríguez RM; Pacheco-Delgado MS
Clin Biochem; 2023 Aug; 118():110610. PubMed ID: 37429509
[TBL] [Abstract][Full Text] [Related]
20. Limitations of Free Light Chain Assays caused by the Matrix Effect.
Farnsworth CW; Logsdon NM; Hayes JE; Rais R; Willrich MA; Gronowski AM
J Appl Lab Med; 2020 Mar; 5(2):311-319. PubMed ID: 32445382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]